NYSE
According to Zyberno, Everforth, Inc. (ASGN) is not a buy — WEAK BUSINESS (36/100) with a negative Margin of Safety of -9.0% and a Brina Gap of +2.5% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, Everforth, Inc. (ASGN) trades at $20.20 against an estimated intrinsic value per share of $18.39 — a -9.0% Margin of Safety based on Owner Earnings of $290.60M TTM, projected at -23.3% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of +2.5% strengthens the case: based on the company's ROIC (3.8%) and reinvestment rate (210.1%), the business can fundamentally grow at 8.0% — but the current enterprise value implies the market expects 5.5%. This places ASGN in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -24.6% annually.
Over the trailing twelve months, ASGN generated $290.60M in Owner Earnings. Capital was deployed as follows: $39.00M returned via share buybacks, $39.00M invested in capital expenditures. Reinvestment rate: 210.1%. Owner Earnings have declined at 23.3% annually over the trailing five years using log-linear regression.